Evidence map›Paper›PMID 29743368›Full record

ArticleJournal of virology2018

STAT2-Dependent Immune Responses Ensure Host Survival despite the Presence of a Potent Viral Antagonist.

Vu Thuy Khanh Le-Trilling, Kerstin Wohlgemuth, Meike U Rückborn, Andreja Jagnjic, Fabienne Maaßen, Lejla Timmer, Benjamin Katschinski, Mirko Trilling

Open access · hybridAbstract read
In one paragraph

Article in Journal of virology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Exposing the Two Contrasting Faces of STAT2 in Inflammation.Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2022
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Vu Thuy Khanh Le-TrillingInstitute for Virology, University Hospital Essen, University Duisburg-Essen, Essen, Germany Khanh.Le@uk-essen.de Mirko.Trilling@uk-essen.de.ORCID https://orcid.org/0000-0002-2733-3732
Kerstin WohlgemuthInstitute for Virology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
Meike U RückbornInstitute for Virology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
Andreja JagnjicInstitute for Virology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
Fabienne MaaßenInstitute for Virology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
Lejla TimmerInstitute for Virology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
Benjamin KatschinskiInstitute for Virology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
Mirko TrillingInstitute for Virology, University Hospital Essen, University Duisburg-Essen, Essen, Germany Khanh.Le@uk-essen.de Mirko.Trilling@uk-essen.de.ORCID https://orcid.org/0000-0003-3659-3541

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A pathogen encounter induces interferons, which signal via Janus kinases and STAT transcription factors to establish an antiviral state. However, the host and pathogens are situated in a continuous arms race which shapes host evolution toward optimized immune responses and the pathogens toward enhanced immune-evasive properties. Mouse cytomegalovirus (MCMV) counteracts interferon responses by pM27-mediated degradation of STAT2, which directly affects the signaling of type I as well as type III interferons. Using MCMV mutants lacking

Indexed as

AnimalsCells, CulturedCytomegalovirus InfectionsImmune EvasionInterferon-gammaMiceMice, Inbred BALB CMice, Inbred C57BLMuromegalovirusSeverity of Illness IndexSignal TransductionSTAT2 Transcription FactorSurvival RateVirus ReplicationInterferon-gammaSTAT2 Transcription Factorcytomegalovirusimmune antagonistsinterferonsin vivoSTAT transcription factors

Identifiers

PMID29743368
PMCPMC6026732
OpenAlexW2801569859

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.